Last reviewed · How we verify
Soybean oil lipid emulsion
At a glance
| Generic name | Soybean oil lipid emulsion |
|---|---|
| Also known as | Intralipid |
| Sponsor | Alexandra N. Carey |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (PHASE2)
- Reprometabolic Syndrome Mediates Subfertility in Obesity (NA)
- Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses (PHASE2)
- Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids (NA)
- Lipid Infusions to Optimize Nutrition Trial (PHASE2)
- Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients (PHASE4)
- Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure (NA)
- A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Soybean oil lipid emulsion CI brief — competitive landscape report
- Soybean oil lipid emulsion updates RSS · CI watch RSS
- Alexandra N. Carey portfolio CI